Vaginal Seeding
Vaginal Seeding
Vaginal Seeding
Vaginal Seeding
ABSTRACT: Vaginal seeding refers to the practice of inoculating a cotton gauze or a cotton swab with vaginal
fluids to transfer the vaginal flora to the mouth, nose, or skin of a newborn infant. The intended purpose of vaginal
seeding is to transfer maternal vaginal bacteria to the newborn. As the increase in the frequency of asthma, atopic
disease, and immune disorders mirrors the increase in the rate of cesarean delivery, the theory of vaginal seeding
is to allow for proper colonization of the fetal gut and, therefore, reduce the subsequent risk of asthma, atopic
disease, and immune disorders. At this time, vaginal seeding should not be performed outside the context of an
institutional review board-approved research protocol until adequate data regarding the safety and benefit of the
process become available.
VOL. 130, NO. 5, NOVEMBER 2017 Committee Opinion Vaginal Seeding e275
clostridial numbers. Although the authors conclude that Microbiota Restoration in the
abnormal development of intestinal microbiota after Newborn Infant Born by Cesarean
cesarean delivery may continue beyond infancy, the rela- Delivery
tionship between vaginal birth, clostridial colonization,
and asthma remains unclear. The microbiota of all infants born by cesarean delivery
cannot be considered uniformly because some infants are
Childhood Asthma born by cesarean delivery after onset of labor or the rup-
Asthma is the most prevalent pediatric chronic disease ture of membrane whereas other infants are born before
and it affects more than 300 million people (13). One the onset of labor or before the rupture of membranes.
child in 10 in the Western world has asthma. A multi- Therefore, exposure to maternal vaginal bacteria will vary
tude of risk factors for the development of asthma have among all infants born by cesarean delivery. A pilot study
been identified. Childhood exposure to environmental of 18 newborns (7 born vaginally and 11 by cesarean
allergens, air pollution, and particulate matter and delivery) and their mothers was conducted in an attempt
viral respiratory tract infections are all associated with to partially restore the microbiota of infants born by
an increased risk of developing childhood asthma (14). cesarean delivery using vaginal microbial transfer (vagi-
The risk of developing asthma has also been associ- nal seeding) (18). Four of the 11 infants born by cesarean
ated with the type of bacteria contributing to the gut delivery were exposed to vaginal fluids from gauze inocu-
microbiota during the first 100 days of life. Infants lated in the vaginas of their respective mothers who were
monitored in the Canadian Healthy Infant Longitudinal negative for group B streptococci, had no signs of vagi-
Development study who were found to be at risk of devel- nosis, and had a vaginal pH less than 4.5, during the hour
oping asthma had relative decreases in the abundances of preceding cesarean delivery. Within 2 minutes of birth,
the genus Lachnospira (associated with atopic wheezing the infants were wiped with the gauze along the mouth,
in children) and increases in the species Clostridium neo- face, and skin. Serial cultures from the anus, mouth,
natale (associated with neonatal necrotizing enterocolitis) and skin of the infants and women were taken during
compared with matched controls (15). The authors con- the first month of life. Cultures were obtained from all
clude that the opposing shifts in the abundance of these 18 infants and women. Bacterial source tracking of the
two species in the first 3 months of life suggest they play infant microbiome revealed that the microbiome of the
a role in protecting against (Lachnospira) or promoting four infants born by cesarean delivery and wiped with the
(C neonatale) the development of asthmatic phenotypes inoculated gauze resembled that of infants delivered vagi-
seen in preschool-aged children. Infants born by cesarean nally, particularly so during the first week of life. Effects
delivery are known to have greater colonization with upon the microbiome beyond the first 30 days of life
Clostridium within the first 3 weeks of life though not at and the effects upon long-term health of the four infants
180 days (11). are not known. The results of this study have generated
Recently, factors have been identified that may interest in the scientific community and even larger inter-
reduce the risk of developing asthma, including envi- est in the international lay population and social media.
ronmental exposures after birth and increased intake of However, as only four infants underwent vaginal seeding,
n-3 fatty acids. A study of Amish and Hutterite children, this study has neither the size nor the power to produce
which included a mouse model, examined exposure to appropriate conclusions or recommendations or to con-
Amish house dust (which has significantly higher endo- firm the safety of vaginal seeding. Additional larger scale
toxin levels) and indicated that the Amish environment studies are necessary to further explore potential benefits
provides protection against asthma by engaging and shap- and risks of this practice.
ing the innate immune response (16). In a separate ran-
domized trial, 736 pregnant women were assigned to Clinical Considerations
receive daily supplemental fish oil (n-3 long-chain poly- It is critical to note that the current state of cumulative
unsaturated fatty acids) or placebo (olive oil) beginning investigative data into the potential benefit and harm
at 24 weeks of gestation through the first postpartum of vaginal seeding at this time consists of a single pilot
week to assess the benefit of fish oil supplementation on study in which only four infants underwent seeding, with
wheezing disorders in offspring. The cohort of 695 chil- no long-term follow up. It is also critical to note that the
dren from these pregnancies was observed for 5 years. The pilot study involved only women who were not carriers
risk of persistent wheeze or asthma was reduced by one of group B streptococci, had no signs of vaginosis, and
third in the first 5 years of life among the children born had a vaginal pH less than 4.5. Because 20% of pregnant
to women who received fish oil supplementation (17). women at term are carriers of group B streptococci, the
In light of the broad evidence of environmental, risk of performing vaginal seeding in the general popu-
dietary, and genetic factors that affect the risk of develop- lation is unknown. Of additional concern is the risk of
ing asthma, the contribution of variations in early micro- undiagnosed C trachomatis, N gonorrhea, human papil-
biota of children associated with delivery route remains loma virus, group A streptococci, and herpes simplex
unknown. virus infections, among others, at the time of delivery
VOL. 130, NO. 5, NOVEMBER 2017 Committee Opinion Vaginal Seeding e277
microbiota of cesarean-born infants via vaginal microbial Copyright November 2017 by the American College of Obstetricians
transfer. Nat Med 2016;22:250–3. ^ and Gynecologists. All rights reserved. No part of this publication may
19. New York University School of Medicine. Potential be reproduced, stored in a retrieval system, posted on the Internet,
or transmitted, in any form or by any means, electronic, mechanical,
Restoration of the Infant Microbiome (PRIME). In: photocopying, recording, or otherwise, without prior written permis-
ClinicalTrials.gov. Bethesda (MD): National Library of sion from the publisher.
Medicine; 2015. ^ Requests for authorization to make photocopies should be directed
to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA
01923, (978) 750-8400.
The American College of Obstetricians and Gynecologists
409 12th Street, SW, PO Box 96920, Washington, DC 20090-6920
Vaginal seeding. Committee Opinion No. 725. American College of
Obstetricians and Gynecologists. Obstet Gynecol 2017:130:e274–8.
This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is
voluntary. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care.
It is not intended to substitute for the independent professional judgment of the treating clinician. Variations in practice may be warranted when, in
the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or
advances in knowledge or technology. The American College of Obstetricians and Gynecologists reviews its publications regularly; however, its publica-
tions may not reflect the most recent evidence. Any updates to this document can be found on www.acog.org or by calling the ACOG Resource Center.
While ACOG makes every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy,
reliability, or otherwise, either express or implied. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or
person. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabili-
ties, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.